These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Gordon T; Castelli WP; Hjortland MC; Kannel WB; Dawber TR Ann Intern Med; 1977 Oct; 87(4):393-7. PubMed ID: 199096 [TBL] [Abstract][Full Text] [Related]
4. Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). Sone H; Tanaka S; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ohashi Y; Akanuma Y; Yamada N; J Clin Endocrinol Metab; 2011 Nov; 96(11):3448-56. PubMed ID: 21865372 [TBL] [Abstract][Full Text] [Related]
5. Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. Connelly PW; MacLean DR; Horlick L; O'Connor B; Petrasovits A; Little JA CMAJ; 1992 Jun; 146(11):1977-87. PubMed ID: 1596847 [TBL] [Abstract][Full Text] [Related]
6. Hematocrit and the risk of coronary heart disease mortality. Brown DW; Giles WH; Croft JB Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356 [TBL] [Abstract][Full Text] [Related]
7. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Lloyd-Jones DM; Wilson PW; Larson MG; Leip E; Beiser A; D'Agostino RB; Cleeman JI; Levy D Arch Intern Med; 2003 Sep; 163(16):1966-72. PubMed ID: 12963571 [TBL] [Abstract][Full Text] [Related]
8. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Onat A; Can G; Ayhan E; Kaya Z; Hergenç G Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555 [TBL] [Abstract][Full Text] [Related]
9. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Kannel WB; Castelli WP; Gordon T; McNamara PM Ann Intern Med; 1971 Jan; 74(1):1-12. PubMed ID: 5539274 [No Abstract] [Full Text] [Related]
10. Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference. Onat A; Can G; Hergenç G; Uğur M; Yüksel H Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):643-50. PubMed ID: 21315565 [TBL] [Abstract][Full Text] [Related]
11. Lipoproteins, cardiovascular disease, and death. The Framingham study. Gordon T; Kannel WB; Castelli WP; Dawber TR Arch Intern Med; 1981 Aug; 141(9):1128-31. PubMed ID: 7259370 [TBL] [Abstract][Full Text] [Related]
12. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. Greenland P; Knoll MD; Stamler J; Neaton JD; Dyer AR; Garside DB; Wilson PW JAMA; 2003 Aug; 290(7):891-7. PubMed ID: 12928465 [TBL] [Abstract][Full Text] [Related]
13. High risk for coronary heart disease in Thiruvananthapuram city: a study of serum lipids and other risk factors. Joseph A; Kutty VR; Soman CR Indian Heart J; 2000; 52(1):29-35. PubMed ID: 10820930 [TBL] [Abstract][Full Text] [Related]
14. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. Castelli WP; Garrison RJ; Wilson PW; Abbott RD; Kalousdian S; Kannel WB JAMA; 1986 Nov; 256(20):2835-8. PubMed ID: 3773200 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of risk factors for coronary heart disease in a mountain community in northern Italy. Pasini GF; Donato F; Buizza MA; Fantoni C; Gelatti U; Tani M; Grassi V G Ital Cardiol; 1999 Aug; 29(8):891-7. PubMed ID: 10488451 [TBL] [Abstract][Full Text] [Related]
17. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study. Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349 [TBL] [Abstract][Full Text] [Related]
18. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Ko M; Kim MT; Nam JJ Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690 [TBL] [Abstract][Full Text] [Related]
20. Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians. Pitla S; Nagalla B Ann Nutr Metab; 2009; 54(1):1-6. PubMed ID: 19194102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]